{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:18Z","timestamp":1787800818533,"version":"build-2784847793"},"reference-count":111,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,27]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Thromboembolic and atherosclerotic disorders, necessitating antithrombotic therapies, are prevalent among patients with advanced chronic kidney disease (CKD), as well as in kidney transplant (KT) recipients. However, the optimal management of antithrombotic therapies in these patients remains uncertain due to conflicting evidence and the exclusion of advanced CKD and KT recipients from major randomized controlled trials. Additionally, the perioperative management of antithrombotic therapy in end-stage kidney disease patients undergoing transplantation requires specific attention. This clinical practice document prepared by experts from the DESCaRTES Working Group of the European Renal Association (ERA) and European Kidney Transplant Association (EKITA) from European Society of Organ Transplantation (ESOT) following European Renal Best Practice (ERBP) guidelines is designed to support clinicians in decision making on antithrombotic therapies in KT candidates and recipients. Following a detailed systematic literature review, it presents current knowledge in epidemiology and pathophysiology and summarizes all relevant studies in this topic.<\/jats:p>","DOI":"10.1093\/ndt\/gfag024","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T12:40:21Z","timestamp":1770468021000},"page":"1736-1754","source":"Crossref","is-referenced-by-count":1,"title":["Management of antithrombotic therapies in kidney transplantation candidates and recipients: an ERBP clinical practice document by the DESCaRTES Working Group of ERA and the EKITA Committee of ESOT"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9750-7585","authenticated-orcid":false,"given":"Arzu","family":"Velioglu","sequence":"first","affiliation":[{"name":"Marmara University School of Medicine Department of Nephrology, , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-1422","authenticated-orcid":false,"given":"Artemios G","family":"Karagiannidis","sequence":"additional","affiliation":[{"name":"First Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0128-5645","authenticated-orcid":false,"given":"Erol","family":"Demir","sequence":"additional","affiliation":[{"name":"Transplant Immunology Research Centre of Excellence, Ko\u00e7 University Hospital , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hellemans","sequence":"additional","affiliation":[{"name":"Antwerp University Hospital Department of Nephrology-Hypertension, , Edegem ,","place":["Belgium"]},{"name":"Faculty of Medicine & Health Sciences, Laboratory of Experimental Medicine and Paediatrics (LEMP), University of Antwerp , Wilrijk ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0485-851X","authenticated-orcid":false,"given":"Ilaria","family":"Gandolfini","sequence":"additional","affiliation":[{"name":"Nephrology Unit, University Hospital of Parma , Parma ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Thomas","sequence":"additional","affiliation":[{"name":"Edinburgh Transplant Centre, Royal Infirmary of Edinburgh , Edinburgh ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelis","family":"de Weerd","sequence":"additional","affiliation":[{"name":"University Medical Center Rotterdam Department of Internal Medicine, Erasmus MC Transplant Institute, , Rotterdam , The","place":["Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8246-4268","authenticated-orcid":false,"given":"Ivana","family":"Dedinska","sequence":"additional","affiliation":[{"name":"Transplant-Nephrology Department Centre, Jessenius Faculty of Medicine, Comenius University and University Hospital Martin , Martin ,","place":["Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kousios","sequence":"additional","affiliation":[{"name":"School of Medicine, European University of Cyprus , Engomi ,","place":["Cyprus"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Samo\u0161","sequence":"additional","affiliation":[{"name":"1st Department of Internal Medicine, Jessenius Faculty of Medicine, University Hospital Martin, Comenius University in Bratislava , Martin ,","place":["Slovakia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhan Diz","family":"K\u00fc\u00e7\u00fckkaya","sequence":"additional","affiliation":[{"name":"\u0130stanbul University Faculty of Science Department of Molecular Biology and Genetics, , Istanbul ,","place":["T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3898-2575","authenticated-orcid":false,"given":"Helen","family":"Erlandsson","sequence":"additional","affiliation":[{"name":"Intervention and Technology, Division of Renal Medicine, Karolinska Institutet Department of Clinical Science, , Stockholm ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-9136","authenticated-orcid":false,"given":"Adnan","family":"Sharif","sequence":"additional","affiliation":[{"name":"University Hospitals Birmingham, Queen Elizabeth Hospital Department of Nephrology and Transplantation, , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schiffer","sequence":"additional","affiliation":[{"name":"University Hospital Erlangen, Friedrich-Alexander University Erlangen-N\u00fcrnberg Department of Nephrology and Hypertension, , Erlangen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Mariat","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie, Dialyse et Transplantation R\u00e9nale, H\u00f4pital Nord, CHU de Saint-Etienne, Universit\u00e9 Jean Monnet , Saint-Etienne ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-9765","authenticated-orcid":false,"given":"Luuk","family":"Hilbrands","sequence":"additional","affiliation":[{"name":"Radboud University Medical Center Department of Nephrology, , Nijmegen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"2026082623115686300_bib1","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026082623115686300_bib2","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/j.jacc.2019.08.1031","article-title":"Anticoagulation in concomitant chronic kidney disease and atrial fibrillation","volume":"74","author":"Kumar","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026082623115686300_bib3","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"2026082623115686300_bib4","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1681\/ASN.2004070580","article-title":"Incidence and predictors of myocardial infarction after kidney transplantation","volume":"16","author":"Lentine","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026082623115686300_bib5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2215\/CJN.00920805","article-title":"Incidence, predictors, and associated outcomes of atrial fibrillation after kidney transplantation","volume":"1","author":"Lentine","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026082623115686300_bib6","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.2215\/CJN.03080707","article-title":"Variations in the risk for cerebrovascular events after kidney transplant compared with experience on the waiting list and after graft failure","volume":"3","author":"Lentine","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026082623115686300_bib7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/joim.13459","article-title":"Scoring of medial arterial calcification predicts cardiovascular events and mortality after kidney transplantation","volume":"291","author":"Erlandsson","year":"2022","journal-title":"J Intern Med"},{"key":"2026082623115686300_bib8","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000480304","article-title":"Venous thromboembolism and the risk of death and graft loss in kidney transplant recipients","volume":"46","author":"Lam","year":"2017","journal-title":"Am J Nephrol"},{"key":"2026082623115686300_bib9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2215\/CJN.04100321","article-title":"Platelet abnormalities in CKD and their implications for antiplatelet therapy","volume":"17","author":"Baaten","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026082623115686300_bib10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/ndt\/gft209","article-title":"Haemostasis in chronic kidney disease","volume":"29","author":"Lutz","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623115686300_bib11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.atherosclerosis.2015.01.034","article-title":"Urea-induced ROS cause endothelial dysfunction in chronic renal failure","volume":"239","author":"D\u2019Apolito","year":"2015","journal-title":"Atherosclerosis"},{"key":"2026082623115686300_bib12","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/ajh.20720","article-title":"Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa","volume":"81","author":"Thekkedath","year":"2006","journal-title":"Am J Hematol"},{"key":"2026082623115686300_bib13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1139\/Y10-111","article-title":"Increased nitric oxide production in platelets from severe chronic renal failure patients","volume":"89","author":"Alves De S\u00e1 Siqueira","year":"2011","journal-title":"Can J Physiol Pharmacol"},{"key":"2026082623115686300_bib14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1172\/JCI110824","article-title":"Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect","volume":"71","author":"Remuzzi","year":"1983","journal-title":"J Clin Invest"},{"key":"2026082623115686300_bib15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jth.14360","article-title":"Red blood cells: the forgotten player in hemostasis and thrombosis","volume":"17","author":"Weisel","year":"2019","journal-title":"J Thromb Haemost"},{"key":"2026082623115686300_bib16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/jth.12141","article-title":"Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups","volume":"11","author":"Ocak","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2026082623115686300_bib17","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1681\/ASN.2020101440","article-title":"Platelet function in CKD: a systematic review and meta-analysis","volume":"32","author":"Baaten","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"2026082623115686300_bib18","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1097\/TP.0000000000004452","article-title":"Pathophysiological changes in the hemostatic system and antithrombotic management in kidney transplant recipients","volume":"107","author":"Van Den Berg","year":"2023","journal-title":"Transplantation"},{"key":"2026082623115686300_bib19","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026082623115686300_bib20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1525-139X.2006.00179.x","article-title":"Hematology: issues in the dialysis patient: platelet dysfunction and end-stage renal disease","volume":"19","author":"Kaw","year":"2006","journal-title":"Semin Dial"},{"key":"2026082623115686300_bib21","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.xkme.2021.04.006","article-title":"Hemodialysis-related complement and contact pathway activation and cardiovascular risk: a narrative review","volume":"3","author":"Skinner","year":"2021","journal-title":"Kidney Med"},{"key":"2026082623115686300_bib22","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1681\/ASN.V85799","article-title":"Studies on platelet membrane glycoproteins and platelet function during hemodialysis","volume":"8","author":"Sloand","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"2026082623115686300_bib23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ki.2012.130","article-title":"Hemodialysis effect on platelet count and function and hemodialysis-associated thrombocytopenia","volume":"82","author":"Daugirdas","year":"2012","journal-title":"Kidney Int"},{"key":"2026082623115686300_bib24","doi-asserted-by":"publisher","first-page":"e0200537","DOI":"10.1371\/journal.pone.0200537","article-title":"Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors","volume":"13","author":"Nieuwenhuijs-Moeke","year":"2018","journal-title":"PLoS One"},{"key":"2026082623115686300_bib25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/tri.13387","article-title":"Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation\u2014a retrospective study","volume":"32","author":"Berg","year":"2019","journal-title":"Transpl Int"},{"key":"2026082623115686300_bib26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/tri.12926","article-title":"Postoperative surgical-site hemorrhage after kidney transplantation: incidence, risk factors, and outcomes","volume":"30","author":"Hachem","year":"2017","journal-title":"Transpl Int"},{"key":"2026082623115686300_bib27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.kint.2024.07.030","article-title":"Transfusion-induced HLA sensitization in wait-list patients and kidney transplant recipients","volume":"106","author":"Willicombe","year":"2024","journal-title":"Kidney Int"},{"key":"2026082623115686300_bib28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11255-024-04247-7","article-title":"Use of fibrin sealant in vein anastomosis in renal transplantation and its effect in preventing blood loss and postoperative peri-graft collection","volume":"57","author":"Dongol","year":"2024","journal-title":"Int Urol Nephrol"},{"key":"2026082623115686300_bib29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/TP.0000000000002510","article-title":"Antiphospholipid syndrome and renal allograft thrombosis","volume":"103","author":"Morales","year":"2019","journal-title":"Transplantation"},{"key":"2026082623115686300_bib30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1681\/ASN.2013121289","article-title":"Platelets in early antibody-mediated rejection of renal transplants","volume":"26","author":"Kuo","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2026082623115686300_bib31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/TP.0000000000000887","article-title":"Hypercoagulability in kidney transplant recipients","volume":"100","author":"Parajuli","year":"2016","journal-title":"Transplantation"},{"key":"2026082623115686300_bib32","doi-asserted-by":"publisher","first-page":"2154330","DOI":"10.1080\/09537104.2022.2154330","article-title":"Treatment inequity in antiplatelet therapy for ischaemic heart disease in patients with advanced chronic kidney disease: releasing the evidence vacuum","volume":"34","author":"Varian","year":"2023","journal-title":"Platelets"},{"key":"2026082623115686300_bib33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/14017431.2019.1598571","article-title":"High on-clopidogrel platelet reactivity and chronic kidney disease: a meta-analysis of literature studies","volume":"53","author":"Wu","year":"2019","journal-title":"Scand Cardiovasc J"},{"key":"2026082623115686300_bib34","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/CIRCULATIONAHA.118.034790","article-title":"Study of two dose regimens of ticagrelor compared with clopidogrel in patients undergoing percutaneous coronary intervention for stable coronary artery disease","volume":"138","author":"Orme","year":"2018","journal-title":"Circulation"},{"key":"2026082623115686300_bib35","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s11239-017-1529-6","article-title":"Benefits and risks of P2Y12 inhibitor preloading in patients with acute coronary syndrome and stable angina","volume":"44","author":"Bazemore","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"2026082623115686300_bib36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ckj\/sfu080","article-title":"Anticoagulation in chronic kidney disease patients\u2014the practical aspects","volume":"7","author":"Hughes","year":"2014","journal-title":"Clin Kidney J"},{"key":"2026082623115686300_bib37","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/bmj.325.7367.762","article-title":"An overview of antithrombotic therapy","volume":"325","author":"Blann","year":"2002","journal-title":"BMJ"},{"key":"2026082623115686300_bib38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/ndt\/gfu334","article-title":"Warfarin use, mortality, bleeding and stroke in haemodialysis patients with atrial fibrillation","volume":"30","author":"Genovesi","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623115686300_bib39","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/ki.2009.477","article-title":"Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy","volume":"77","author":"Wizemann","year":"2010","journal-title":"Kidney Int"},{"key":"2026082623115686300_bib40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1053\/j.ackd.2006.10.007","article-title":"Mechanisms of vascular calcification","volume":"14","author":"El-Abbadi","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"2026082623115686300_bib41","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1001\/archinte.159.15.1750","article-title":"Long-term use of oral anticoagulants and the risk of fracture","volume":"159","author":"Caraballo","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026082623115686300_bib42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s40620-020-00720-5","article-title":"Systematic DOACs oral anticoagulation in patients with atrial fibrillation and chronic kidney disease: the nephrologist\u2019s perspective","volume":"33","author":"Ravera","year":"2020","journal-title":"J Nephrol"},{"key":"2026082623115686300_bib43","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.jtha.2024.07.009","article-title":"Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH","volume":"22","author":"Levy","year":"2024","journal-title":"J Thromb Haemost"},{"key":"2026082623115686300_bib44","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40262-016-0417-0","article-title":"Effect of age and renal function on idarucizumab pharmacokinetics and idarucizumab-mediated reversal of dabigatran anticoagulant activity in a randomized, double-blind, crossover phase Ib study","volume":"56","author":"Glund","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"2026082623115686300_bib45","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jacc.2019.07.070","article-title":"Dabigatran reversal with idarucizumab in patients with renal impairment","volume":"74","author":"Eikelboom","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026082623115686300_bib46","doi-asserted-by":"publisher","first-page":"e12509","DOI":"10.1002\/rth2.12509","article-title":"Antithrombotics and new interventions for venous thromboembolism: exploring possibilities beyond factor IIa and factor Xa inhibition","volume":"5","author":"Mavromanoli","year":"2021","journal-title":"Res Prac Thromb Haemost"},{"key":"2026082623115686300_bib47","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ekir.2024.10.007","article-title":"A systematic review of safety and efficacy of factor XI\/XIa inhibitors in patients with ESKD on hemodialysis","volume":"10","author":"Steiner","year":"2025","journal-title":"Kidney Int Rep"},{"key":"2026082623115686300_bib48","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the Management of Atrial Fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Developed with the special contribution of the European Heart Rhythm Association (EHRA), Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), Authors\/Task Force Members","year":"2010","journal-title":"Eur Heart J"},{"key":"2026082623115686300_bib49","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.3390\/jcm11144025","article-title":"Predictive Value of HAS-BLED score regarding bleeding events and graft survival following renal transplantation","volume":"11","author":"Hau","year":"2022","journal-title":"J Clin Med"},{"key":"2026082623115686300_bib50","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/ndt\/gfy387","article-title":"Performance of bleeding risk scores in dialysis patients","volume":"34","author":"Ocak","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623115686300_bib51","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1538-7836.2010.04085.x","article-title":"A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice","volume":"9","author":"Van Staa","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2026082623115686300_bib52","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/ckj\/sfac260","article-title":"Stroke in hemodialysis patients and its association with CHA2DS2-VASC and HAS-BLED scores: a retrospective study","volume":"16","author":"Sab","year":"2023","journal-title":"Clin Kidney J"},{"key":"2026082623115686300_bib53","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/ndt\/15.11.1865","article-title":"Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients","volume":"15","author":"Robertson","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623115686300_bib54","first-page":"291","article-title":"The platelet transfusion is ineffective to prevent risk of bleeding during renal transplantation surgery in patients on chronic treatment with acetylsalicylic acid","volume":"12","author":"Rodriguez-Pastore","year":"2012","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib55","first-page":"77","article-title":"Clopidogrel is associated with decreased survival in renal transplant recipients","volume":"14","author":"Kapeles","year":"2014","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib56","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1097\/01.tp.0000885992.19440.20","article-title":"242.5: Comparative analysis of perioperative complications in kidney transplant patients with coronary artery disease on dual antiplatelet therapy (DAPT)","volume":"106","author":"Bansal","year":"2022","journal-title":"Transplantation"},{"key":"2026082623115686300_bib57","doi-asserted-by":"publisher","first-page":"100594","DOI":"10.1016\/j.trre.2020.100594","article-title":"Comparison of the effect of single vs dual antiplatelet agents on post-operative haemorrhage after renal transplantation: a systematic review and meta-analysis","volume":"35","author":"Lee","year":"2021","journal-title":"Transplant Rev (Orlando)"},{"key":"2026082623115686300_bib58","first-page":"10","article-title":"One-year allograft and patient survival in renal transplant recipients receiving antiplatelet therapy at the time of transplantation","volume":"9","author":"Benk\u00f6","year":"2018","journal-title":"Int J Organ Transplant Med"},{"key":"2026082623115686300_bib59","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40620-015-0185-1","article-title":"Impact of pre-transplant antiaggregant and anticoagulant therapies on early hemorrhagic and cardiovascular events after kidney transplantation","volume":"28","author":"Musetti","year":"2015","journal-title":"J Nephrol"},{"key":"2026082623115686300_bib60","article-title":"Outcomes of kidney transplant recipients on dual antiplatelet therapy","volume":"2","author":"Bailey","year":"2015","journal-title":"Austin J Nephrol Hypertens"},{"key":"2026082623115686300_bib61","article-title":"Complications of dual antiplatelet therapy among recipients of kidney transplants","volume":"16","author":"Weng","year":"2016","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib62","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1093\/ndt\/gfl338","article-title":"Retrospective analysis of surgical complications following cadaveric kidney transplantation in the modern transplant era","volume":"21","author":"Hern\u00e1ndez","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623115686300_bib63","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/ndt\/gft385","article-title":"Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study","volume":"29","author":"Benahmed","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"2026082623115686300_bib64","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1097\/TP.0b013e3181bc03ab","article-title":"Effect of hemodialysis before transplant surgery on renal allograft function\u2014a pair of randomized controlled trials","volume":"88","author":"Kiki\u0107","year":"2009","journal-title":"Transplantation"},{"key":"2026082623115686300_bib65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/joneph\/23.5.587","article-title":"The impact of peritransplant warfarin use on renal transplant outcome","volume":"23","author":"Connaughton","year":"2010","journal-title":"J Nephrol"},{"key":"2026082623115686300_bib66","first-page":"A25","article-title":"Outcomes of kidney transplant recipients on warfarin at time of transplant","volume":"11","author":"Wong","year":"2006","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib67","first-page":"s579","article-title":"Renal transplantation can be performed safely without pre-operative apixaban reversal","volume":"23","author":"Littlejohn","year":"2023","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib68","doi-asserted-by":"publisher","first-page":"e14148","DOI":"10.1111\/ctr.14148","article-title":"Deceased donor renal transplantation in patients on apixaban at time of transplant surgery: a case series","volume":"35","author":"Lange","year":"2021","journal-title":"Clin Transplant"},{"key":"2026082623115686300_bib69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/2047-1440-2-4","article-title":"Blood transfusion in deceased donor kidney transplantation","volume":"2","author":"Marzouk","year":"2013","journal-title":"Transplant Res"},{"key":"2026082623115686300_bib70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1399-0012.2010.01293.x","article-title":"Perioperative anticoagulation and antiplatelet therapy in renal transplant: is there an increase in bleeding complication?","volume":"25","author":"Eng","year":"2011","journal-title":"Clin Transplant"},{"key":"2026082623115686300_bib71","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/ctr.12513","article-title":"Surgical complications after kidney transplantation: different impacts of immunosuppression, graft function, patient variables, and surgical performance","volume":"29","author":"Koch","year":"2015","journal-title":"Clin Transplant"},{"key":"2026082623115686300_bib72","first-page":"998","article-title":"Evaluation of clinical outcomes in patients receiving antithrombotic therapy prior to kidney transplantation","volume":"20","author":"Diamond","year":"2020","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib73","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.931648","article-title":"Is continuing anticoagulation or antiplatelet therapy safe prior to kidney transplantation?","volume":"26","author":"Alonso-Escalante","year":"2021","journal-title":"Ann Transplant"},{"key":"2026082623115686300_bib74","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/0003134820923313","article-title":"Operative versus nonoperative management of hemorrhage in the postoperative kidney transplant patient","volume":"86","author":"Buggs","year":"2020","journal-title":"Am Surg"},{"key":"2026082623115686300_bib75","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1093\/eurheartj\/ehac270","article-title":"2022 ESC guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery","volume":"43","author":"Halvorsen","year":"2022","journal-title":"Eur Heart J"},{"key":"2026082623115686300_bib76","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.chest.2022.07.025","article-title":"Perioperative management of antithrombotic therapy","volume":"162","author":"Douketis","year":"2022","journal-title":"Chest"},{"key":"2026082623115686300_bib77","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00007890-198911000-00038","article-title":"Subcutaneous heparin therapy for cyclosporine-immunosuppressed renal allograft recipients","volume":"48","author":"Ubhi","year":"1989","journal-title":"Transplantation"},{"key":"2026082623115686300_bib78","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/00007890-199808270-00020","article-title":"Efficacy and safety of low molecular weight heparin in renal transplantation","volume":"66","author":"Alkhunaizi","year":"1998","journal-title":"Transplantation"},{"key":"2026082623115686300_bib79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.urology.2006.12.017","article-title":"Necessity of routine postoperative heparinization in non-risky live-donor renal transplantation: results of a prospective randomized trial","volume":"69","author":"Osman","year":"2007","journal-title":"Urology"},{"key":"2026082623115686300_bib80","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3109\/2000-1967-137","article-title":"Low molecular weight heparin prophylaxis increases the incidence of lymphocele after kidney transplantation","volume":"107","author":"Lundin","year":"2002","journal-title":"Ups J Med Sci"},{"key":"2026082623115686300_bib81","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v69i2.1538","article-title":"Evaluation of Heparin Anticoagulation Protocols in Post\u2013Renal Transplant Recipients (EHAP-PoRT Study)","volume":"69","author":"Ng","year":"2016","journal-title":"Can J Hosp Pharm"},{"key":"2026082623115686300_bib82","doi-asserted-by":"publisher","first-page":"E162","DOI":"10.1503\/cjs.021821","article-title":"The epidemiology of early deep vein thrombosis in kidney transplant recipients","volume":"66","author":"Qu","year":"2023","journal-title":"Can J Surg"},{"key":"2026082623115686300_bib83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1046\/j.1365-2168.2001.01671.x","article-title":"Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation","volume":"88","author":"Murphy","year":"2001","journal-title":"J Br Surg"},{"key":"2026082623115686300_bib84","doi-asserted-by":"publisher","DOI":"10.12659\/AOT.939143","article-title":"Incidence of thromboembolic complications following kidney transplantation with short and extended aspirin prophylaxis: a retrospective single-center study","volume":"28","author":"Pegler","year":"2023","journal-title":"Ann Transplant"},{"key":"2026082623115686300_bib85","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.euf.2024.10.010","article-title":"European Association of Urology Guidelines on Renal Transplantation: update 2024","volume-title":"Eur Urol Focus","author":"Faba","year":"2025"},{"key":"2026082623115686300_bib86","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","article-title":"Renal association clinical practice guideline in post-operative care in the kidney transplant recipient","volume":"18","author":"Baker","year":"2017","journal-title":"BMC Nephrol"},{"key":"2026082623115686300_bib87","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients","volume":"9","author":"Eckardt","year":"2009","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib88","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026082623115686300_bib89","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/tri.13599","article-title":"Safety and efficacy of direct-acting oral anticoagulants versus warfarin in kidney transplant recipients: a retrospective single-center cohort study","volume":"33","author":"Bixby","year":"2020","journal-title":"Transpl Int"},{"key":"2026082623115686300_bib90","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejim.2023.08.003","article-title":"Immunosuppressive therapy and oral anticoagulation in kidney transplant recipients: direct oral anticoagulants versus vitamin-k antagonists","volume":"119","author":"Santoro","year":"2024","journal-title":"Eur J Intern Med"},{"key":"2026082623115686300_bib91","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2478\/prilozi-2020-0032","article-title":"Novel oral anticoagulants in renal transplant recipients: a retrospective cohort study","volume":"41","author":"Basic-Jukic","year":"2020","journal-title":"Pril (Makedon Akad Nauk Umet Odd Med Nauki)"},{"key":"2026082623115686300_bib92","doi-asserted-by":"publisher","first-page":"134","DOI":"10.5500\/wjt.v9.i6.134","article-title":"Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation","volume":"9","author":"Bukhari","year":"2019","journal-title":"World J Transplant"},{"key":"2026082623115686300_bib93","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/FTD.0000000000000858","article-title":"Apixaban level and its influence on immunosuppression and graft outcome in kidney transplant recipients with atrial fibrillation","volume":"43","author":"Green","year":"2021","journal-title":"Ther Drug Monit"},{"key":"2026082623115686300_bib94","doi-asserted-by":"publisher","first-page":"e14474","DOI":"10.1111\/ctr.14474","article-title":"Can direct oral anticoagulants be used in kidney transplant recipients?","volume":"35","author":"Parker","year":"2021","journal-title":"Clin Transplant"},{"key":"2026082623115686300_bib95","doi-asserted-by":"publisher","first-page":"e0285412","DOI":"10.1371\/journal.pone.0285412","article-title":"Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients","volume":"18","author":"Firth","year":"2023","journal-title":"PLoS One"},{"key":"2026082623115686300_bib96","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.transproceed.2021.09.042","article-title":"The use of non\u2013vitamin K antagonist oral anticoagulants in post-kidney transplantation, single-center experience","volume-title":"Transplant Proc","author":"Zaitoun","year":"2021"},{"key":"2026082623115686300_bib97","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/tri.13804","article-title":"Safety and efficacy of direct oral anticoagulants under long-term immunosuppressive therapy after liver, kidney and pancreas transplantation","volume":"34","author":"Pfrepper","year":"2021","journal-title":"Transpl Int"},{"key":"2026082623115686300_bib98","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1097\/TP.0000000000003168","article-title":"Efficacy and safety of direct oral anticoagulants in kidney transplantation: a single-center pilot experience","volume":"104","author":"Leon","year":"2020","journal-title":"Transplantation"},{"key":"2026082623115686300_bib99","doi-asserted-by":"publisher","first-page":"106682","DOI":"10.1016\/j.vph.2020.106682","article-title":"Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation","volume":"130","author":"Camporese","year":"2020","journal-title":"Vasc Pharmacol"},{"key":"2026082623115686300_bib100","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/ajt.15406","article-title":"When to hold: apixaban in renal transplant recipients","volume":"19","author":"Do","year":"2019","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib101","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/cts.13284","article-title":"Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients","volume":"15","author":"Mansell","year":"2022","journal-title":"Clin Transl Sci"},{"key":"2026082623115686300_bib102","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/FTD.0000000000000356","article-title":"Effect of the direct oral anticoagulants rivaroxaban and apixaban on the disposition of calcineurin inhibitors in transplant recipients","volume":"39","author":"Vanhove","year":"2017","journal-title":"Ther Drug Monit"},{"key":"2026082623115686300_bib103","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/ajt.13622","article-title":"Complications of ultrasound-guided renal transplant biopsies","volume":"16","author":"Morgan","year":"2016","journal-title":"Am J Transplant"},{"key":"2026082623115686300_bib104","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jvir.2016.10.021","article-title":"Effects of aspirin therapy on ultrasound\u2013guided renal allograft biopsy bleeding complications","volume":"28","author":"Baffour","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"2026082623115686300_bib105","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jacr.2015.12.003","article-title":"Implementation and results of a percutaneous renal allograft biopsy protocol to reduce complication rate","volume":"13","author":"Li","year":"2016","journal-title":"J Am Coll Radiol"},{"key":"2026082623115686300_bib106","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/tri.13090","article-title":"Routine haemostasis testing before transplanted kidney biopsy: a cohort study","volume":"31","author":"Kuiper","year":"2018","journal-title":"Transpl Int"},{"key":"2026082623115686300_bib107","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.34067\/KID.0000332022","article-title":"Percutaneous ultrasound-guided kidney transplant biopsy outcomes: from the nephrologist to the radiologist standpoint","volume":"3","author":"Mattiazzi","year":"2022","journal-title":"Kidney360"},{"key":"2026082623115686300_bib108","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1053\/j.jvca.2025.02.011","article-title":"TEG\u00ae 6s\u2013guided algorithm for optimizing patient blood management in cardiovascular surgery: systematic literature review and expert opinion","volume":"39","author":"Maxey-Jones","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"2026082623115686300_bib109","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"2026082623115686300_bib110","doi-asserted-by":"publisher","first-page":"151484","DOI":"10.1016\/j.semnephrol.2023.151484","article-title":"Factor XI inhibitors: potential role in end-stage kidney disease","volume":"43","author":"Ades","year":"2023","journal-title":"Semin Nephrol"},{"key":"2026082623115686300_bib111","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41591-023-02794-7","article-title":"Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial","volume":"30","author":"Weitz","year":"2024","journal-title":"Nat Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag024\/66820574\/gfag024.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/9\/1736\/66820574\/gfag024.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/9\/1736\/66820574\/gfag024.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:12:10Z","timestamp":1787800330000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/9\/1736\/8469372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":111,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,2,9]]},"published-print":{"date-parts":[[2026,8,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag024","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,2,9]]}}}